Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The national neuromyelitis optica spectrum disorders registry system of Iran (NMORI): Aspects and methodological dimensions.
Factors associated with delays in multiple sclerosis disease-modifying therapy initiation.
Hmgcs1 regulates cholesterol synthesis and promotes nerve fiber repair after spinal cord injury.
Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.
Functional Connectivity Alterations of the Central Autonomic Network in Multiple Sclerosis: Links to Fatigue and Aerobic Training Effects.
Neurodegenerative Diseases in Children: A Comprehensive Review.
Clinical and Demographic Predictors of Optic Neuritis Subtype.
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.
Myelin-oligodendrocyte glycoprotein antibody-associated disease in Crohn's disease: an exceptional neurological manifestation.
Incidence and prevalence of small fibre neuropathy in the Netherlands: a multiple system estimation study.
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4-IgG-Positive NMOSD.
Sex differences in the development, treatment, and prognosis of multiple sclerosis in Switzerland.
Neuroectodermal interleukin 12 signaling attenuates spinal cord inflammation and demyelination.
[Characterization of Immune Reconstitution Patterns in B-cell Subsets Mediated by B-cell Targeted Therapies].
Medical evaluation of first presentation of psychotic symptoms in children and adolescents.
The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation.
Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series.
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.
Central Pontine Myelinolysis Leading to an Intensive Care Unit Admission.
Diffusion tensor imaging-functional MRI fusion reveals disrupted white matter structure-function coupling in HIV-associated asymptomatic neurocognitive impairment.
Response to "comment on 'evidence for compromised function of the glymphatic system in pediatric acquired demyelinating disorders'".
Long-Term Outcome of Aquaporin 4-Positive Neuro Myelitis Optica Spectrum Disorder and Efficacy of Long-Term Immunosuppression - A Single-Center Study from South India.
[Human myelinated brain organoids with integrated microglia as a model for myelin repair and remyelinating therapies].
Assessment of serum FAM19A5 level in patients with Neuromyelitis Optica spectrum disorder.
Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation.
Pages
« first
‹ previous
…
968
969
970
971
972
973
974
975
976
…
next ›
last »